Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

NASDAQ:TGTX

TG Therapeutics (TGTX)

49.52
+1.47 (3.06%)
as of Jun 12, 2026, 8:00:00 pm Market Open.
9 watching
0
BUY

Developing drugs for MS and blood cancers like leukemia. Exciting prospects; boasts promising clinical trial results, especially for their MS drug. Last month, they announced good phase 3 results for that drug which lifted share from the $30's to $50's. Cash flow is fine; they just said they've raised a lot of money.

BUY
A biopharma. Dont sell. Great CEO. It took a long time, but the stock is now paying off.
Showing 1 to 2 of 2 entries
  • «
  • 1
  • »

TG Therapeutics (TGTX) Frequently Asked Questions

What is TG Therapeutics stock symbol?

TG Therapeutics is a American stock, trading under the symbol TGTX (previously TGTX-Q on Stockchase) on the NASDAQ (TGTX). It is usually referred to as NASDAQ:TGTX or TGTX

Is TG Therapeutics a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on TGTX (previously TGTX-Q on Stockchase) on Stockchase. Read the latest expert commentary for TG Therapeutics.

Is TG Therapeutics a good investment or a top pick?

TG Therapeutics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for TG Therapeutics.

Why is TG Therapeutics stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for TG Therapeutics.

Is TG Therapeutics worth watching?

TG Therapeutics is followed by 9 investors on Stockchase and is a trending stock that is worth watching.

What is TG Therapeutics stock price?

On 2026-06-12, TG Therapeutics (TGTX) stock closed at a price of $49.52.